TITAN OF INDUSTRY

Stéphane Bancel discusses the challenges and opportunities in the biopharma industry, emphasizing the high failure rate of drugs in clinical trials, with 90% not getting approved. He highlights the potential of AI to revolutionize drug discovery and development, particularly in creating new molecules and accelerating clinical processes. The conversation also touches on the innovative use of mRNA technology, which has shown promise in personalized medicine and cancer treatment. Bancel shares insights on how AI can aid in early disease diagnosis and improve interactions with regulators. The discussion underscores the importance of integrating AI into healthcare to enhance efficiency and democratize access to medical advancements.